Search
Search Results
##search.searchResults.foundPlural##
-
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1111PDF: 754HTML: 1753 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2462PDF: 890HTML: 15064 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3006PDF: 1521HTML: 248 -
Simultaneous dual pathology in lymph node
1600PDF: 664HTML: 7672Simultaneous dual pathology in lymph node: 155Simultaneous dual pathology in lymph node: 152Simultaneous dual pathology in lymph node: 136Simultaneous dual pathology in lymph node: 168Simultaneous dual pathology in lymph node: 154 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1231PDF: 743HTML: 291 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3096PDF: 1005HTML: 411 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2093PDF: 1150HTML: 3669 -
Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency
1007PDF: 347HTML: 255 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2423PDF: 804HTML: 8784Efremov 1: 204Efremov 2: 161 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1579PDF: 1403HTML: 230 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
661PDF: 448Suppl. Files: 104HTML: 74 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
770PDF: 769HTML: 94 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1338PDF: 893HTML: 1635Figure 1: 157 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3018PDF: 1107HTML: 361 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
782PDF: 552HTML: 259 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1029PDF: 466HTML: 8132 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3787PDF: 1048HTML: 403 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2491PDF: 1562HTML: 2333Table1: 172 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3438PDF: 1023HTML: 864 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1679PDF: 496HTML: 16954Figure 4: 143Figure 3: 125Figure 2: 124Figure 1: 154 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1527PDF: 761HTML: 838jdoe, table 2 infections CML .doc: 170jdoe, table 1 infections CML .doc: 158 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1283PDF: 802HTML: 10011cover letter to the editor: 146tile page: 234 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1171PDF: 867HTML: 277 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1680PDF: 845HTML: 357Fig1: 211Fig.2: 227Fig. 3: 158Fig. 5: 165Fig. 4: 196 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3011PDF: 851HTML: 1522Fig.1 CHL-R paper: 186Fig 2 CHL-R paper: 214







